Yechitatu CMC-China 2021
Nguva: Gunyana 29-30, 2021
Nzvimbo yekuratidzira: CD Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China.
Synergy of Centralized China's Drug Volume-based Purchasing and Medical Insurance Negotiation Policy inowedzera marwadzo ekubatanidzwa kweindasitiri yemishonga uye inovandudza mhando yemishonga yemazuva ese. Kuongororwa uye kubvumidzwa kwemishonga mitsva kwakakwidziridzwa, mutengo wekutaurirana inishuwarenzi yekurapa wakaderedzwa, uye wakaratidzwa. mishonga yakabviswa kubva kuinishuwarenzi yekurapa, ichisunungura nzvimbo yakawanda yemishonga ine chaiyo yekiriniki application kukosha: NMPA kujoinha ICH uye kuitwa kweMAH system kwakawedzera kukurumidza kwemaindasitiri emapurojekiti emishonga matsva.
Kwenguva yakati rebei, indasitiri yemishonga yakanangana ne "innovation" uye yakaregeredza kudiwa kwezvinodhaka zvinoenderana nemamiriro enyika uye neketani yese yeindasitiri yemishonga, senge kubatanidzwa kweiyo API yepakati uye yekutengesa ketani; innovative drugs.Innovation for innovation's sake inhare iri mumhepo.
Ko indasitiri yemishonga ine hunhu hweChinese inofanira kuenda sei mune ramangwana?Iri harisi dambudziko chete padivi remishonga R&D, asiwo kuti cheni yese yeindasitiri yemishonga inoda kufunga nezvazvo.
Gunyana 29 kusvika 30, 2021, yechitatu China Chemical and Biological Pharmaceutical Industry Conference ichaitwa muSuzhou International Expo Center. Dingindira remusangano uyu rinoti "Kubatanidza cheni yese yeindasitiri yemishonga kugadzirisa kudiwa kwezvinodhaka kusati kwazadziswa maererano nemamiriro emunyika yeChina. ", Pamusangano, vangangoita 6000 ~ 8000 vatori vechikamu vachakurukura nezve API intermediates, pathway inhibitor, uye kuvandudza uye hunyanzvi, uye kune kwazvino kugadzirwa mishonga mitsva kumativi ese ekuongorora tekinoroji, marongero nemhinduro.
Sezvo musika uchichinja uye marongero ari kuitwa, echinyakare makambani emishonga emishonga ari kusimudzira nekushandura, makambani matsva eBiotech ari kuita howa, uye makambani eCXO ane chekuita nepreclinical, kiriniki neCMC ari kuwedzerawo. , mishonga yemakemikari nemishonga yebhayoloji.Transnational Cooperation License in/out, mubatanidzwa wemhiri kwemakungwa nekutorawo zvakajairika.
Tichipesana nemamiriro ezvinhu aya, isu nemazana emabhizinesi emishonga tinobata pamwe The 3rd China International Biological & Chemical Pharmaceutical Industry Conference (The 3rd CMC-China 2021) muSuzhou, iro guta hombe reindasitiri yemishonga.Maforamu matanhatu edingindira anogadzwa pamusangano uyu, achifukidza munda wese we macro-molecules & madiki mamorekuru, generic uye zvinodhaka zvinodhaka, kumusoro & pasi hova ketani yeanoshanda mishonga yemishonga (API) uye gadziriro dzemishonga.
Pamusangano wechitatu weCMC-China, uchawana kududzirwa kwemutemo weindasitiri yemishonga uye kugovana tekinoroji, kuvhara mishonga yekurwisa antibody, majekiseni uye tekinoroji yemRNA, zvinodhaka zvinodhaka uye generic drug projekiti mvumo, kutsvagisa nekusimudzira, kiriniki nekugadzira, kemikari yakasvibira chaiyo. kurwisa tekinoroji, nezvimwe. Pamusangano, unogona kuwana mamwe mikana yebhizinesi munzvimbo yeanoshanda mishonga yemishonga (API), mishonga yepakati uye yemishonga excipients, packaging zvinhu, zviridzwa, midziyo, consumables, pamwe nemishonga & kiriniki CRO, CMO. uye mapurojekiti ane chekuita neMAH.Pamusangano, iwe uchasangana neboka reindasitiri shamwari uye vanobatana!
Nguva yekutumira: Sep-28-2021